Third Rock Ventures

Latest stories

9d
Boston Globe
Big Pharma’s cash flows in a flurry of partnershipsof five experimental cancer drugs and meet a range of specified clinical and re
Big Pharma’s cash flows in a flurry of partnerships
Boston Globe / Posted 9 days ago
of five experimental cancer drugs and meet a range of specified clinical and regulatory goals. Cary Pfeffer, a partner at Third Rock Ventures, a Boston venture capital firm that has launched and funded dozens of biotech startups, said the pace of... Read more
5 related stories
11d
Boston Globe
Jounce to get $225 million in Celgene dealwith about a dozen Massachusetts biotechs in the past five years. Jounce, laun
Jounce to get $225 million in Celgene deal
Boston Globe / Posted 11 days ago
with about a dozen Massachusetts biotechs in the past five years. Jounce, launched in 2013 by Boston venture capital firm Third Rock Ventures, has raised more than $100 million in private capital. Its name, derived partly from a physics term and... Read more
5 related stories
11d
Business Wire
Third Rock Ventures Launches Fulcrum Therapeutics with $55 Million Series A Investmenton modulating gene regulation via control of genetic on and off switches of dis
Third Rock Ventures Launches Fulcrum Therapeutics with $55 Million Series A Investment
Business Wire / Posted 11 days ago
on modulating gene regulation via control of genetic on and off switches of disease genes. Fulcrum was launched in 2016 by Third Rock Ventures, and is headquartered in Cambridge, Mass. For more information please visit... Read more
15d
MedCity News
Standing on the shoulders of stem cell gene therapistsreporting positive results from patients with adrenokeukodystrohy and beta-thal
Standing on the shoulders of stem cell gene therapists
MedCity News / Posted 15 days ago
reporting positive results from patients with adrenokeukodystrohy and beta-thalassemia, which in turn would catalyze Third Rock Ventures to create a new biotech, bluebirdbio, from its earlier incarnation, Genetix, to drive this work forward.... Read more
16d
Business Wire
Global Genes Announces RARE Champion of Hope Award Recipients to be Honored at the 5th Annual Tribute to Champions of Hope, Presented by PRA Health Sciencessearch for meaningful treatments and has brought hope and compassion to countle
Global Genes Announces RARE Champion of Hope Award Recipients to be Honored at the 5th Annual Tribute to Champions of Hope, Presented by PRA Health Sciences
Business Wire / Posted 16 days ago
search for meaningful treatments and has brought hope and compassion to countless families." In addition to his role at Third Rock Ventures, Reilly is a trustee emeritus of Cornell University, an Overseer of Weill Cornell Medical College, and... Read more
17d
Boston Globe
Biotech veteran Holtzman joins Decibel as CEOdrugs based on the gene-silencing technology RNA interference. Decibel raised
Biotech veteran Holtzman joins Decibel as CEO
Boston Globe / Posted 17 days ago
drugs based on the gene-silencing technology RNA interference. Decibel raised $52 million last fall from investors led by Third Rock Ventures, whose cofounder, Kevin Starr, had been serving as its interim CEO. The company’s scientific cofounders... Read more
17d
Business Wire
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officerto president and chief executive officer. Mr. Holtzman succeeds interim chief e
Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
Business Wire / Posted 17 days ago
to president and chief executive officer. Mr. Holtzman succeeds interim chief executive officer, Kevin Starr, a partner at Third Rock Ventures, who will remain chairman of Decibel Therapeutics’ board of directors. “Steve is a recognized leader in... Read more
18d
Boston Globe
Star power design in Dorchesternot a biotech insider, but became fascinated by the high-risk business of curin
Star power design in Dorchester
Boston Globe / Posted 18 days ago
not a biotech insider, but became fascinated by the high-risk business of curing disease. So she put it her friend, Third Rock Ventures partner Alexis Borisy: “‘I want to make a film or something about a biotech startup. Is there any drama... Read more

People in this news